Oct 21, 2026 10:00AM

Aug 11, 2026 04:52PM

Aug 10, 2026 09:10AM

Aug 6, 2024 04:05PM

Jul 31, 2024 09:01AM

Jul 31, 2024 09:00AM

Nov 30, 2022 02:54PM AbCellera (ABCL) Declines 11% After FDA Pulls Approval for Lilly's Bentelovimab

Jun 29, 2022 11:04AM

Feb 14, 2022 05:43AM

Feb 11, 2022 03:37PM

Feb 11, 2022 03:37PM

Feb 11, 2022 03:37PM

Feb 11, 2022 05:31AM

Feb 10, 2022 07:40PM Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatments

Dec 3, 2021 04:05PM

Dec 3, 2021 04:05PM

Nov 9, 2021 04:05PM

Nov 2, 2021 04:04PM

Sep 21, 2021 01:56PM

Sep 21, 2021 01:55PM

Sep 20, 2021 07:10AM Pay More Attention to AbCellera Biologics (ABCL) on String of Positive News, BMO Says; Analyst Sees ~150% Upside

Sep 17, 2021 09:28AM

Sep 16, 2021 05:56PM

Sep 16, 2021 04:42PM

Sep 16, 2021 04:19PM

Sep 16, 2021 04:15PM

Aug 18, 2021 09:00AM

Jun 22, 2021 09:02AM AbCellera (ABCL) Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada

Jun 22, 2021 09:00AM

May 14, 2021 09:30AM

May 4, 2021 06:30AM

Apr 5, 2021 02:01PM

Apr 5, 2021 02:00PM

Mar 30, 2021 09:21AM

Mar 10, 2021 11:22AM AbCellera (ABCL) -Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19

Mar 10, 2021 11:21AM

Mar 5, 2021 03:33PM

Mar 5, 2021 03:30PM

Feb 11, 2021 04:05PM

Feb 9, 2021 08:26PM

Jan 27, 2021 07:26AM

Jan 27, 2021 07:22AM AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19

Jan 26, 2021 07:10AM

Jan 26, 2021 07:09AM

Jan 21, 2021 08:28AM

Jan 21, 2021 08:27AM

Dec 21, 2020 09:03AM

Dec 21, 2020 09:00AM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All